Nanobiotix S.A. ( NBTX) - Key Metrics
NBTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | ? | ? | ? | ? |
| 2024Q4 | -$0.44 | -$0.98 | -$0.29 | -$0.30 |
| 2024Q2 | $0.20 | -$0.46 | -$0.12 | -$0.13 |
| 2023Q4 | $0.87 | -$0.31 | $0.13 | $0.13 |
| 2023Q2 | $0.09 | -$0.80 | -$0.50 | -$0.51 |
NBTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | ? |
| 2024Q4 | ? | -0.77 |
| 2024Q2 | ? | -2.69 |
| 2023Q4 | ? | -5.44 |
| 2023Q2 | ? | -1.45 |
NBTX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q2 | -9.23% | ? |
| 2024Q4 | -10.74% | ? |
| 2024Q2 | -2.69% | ? |
| 2023Q4 | 1.92% | ? |
| 2023Q2 | -10.99% | ? |
NBTX
Price: $38.31
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.58 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: France
Volume: 700
Market Capitalization: 2.0 billion